CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I Dose Finding Study of Oral LTT462 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02711345
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:34.580643+00:00
- Published At
- 2019-09-19T00:00:00+00:00
- Record Updated At
- 2019-09-19
- Results Posted At
- 2019-09-19
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Ovarian Neoplasms", "Non-Small-Cell Lung Carcinoma", "Melanoma", "Other Solid Tumors"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-09-19"- protocolSection.identificationModule.nctId
"NCT02711345"- protocolSection.identificationModule.officialTitle
"A Phase I Dose Finding Study of Oral LTT462 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations."- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-09-19"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.